NWSA
71
-4
SWKS
60
-5
MPC
38
2
CRM
47
-2
PGR
69
5
NVDA
66
-2
MMC
67
2
SWK
56
3
HIG
71
4
SLB
37
5
GE
65
8
BLK
64
17
AZO
50
7
PG
58
3
NWS
69
-4
COST
74
2
WFC
58
3
WRK
52
2
VMC
62
2
CAG
31
-2
NWSA
71
-4
SWKS
60
-5
MPC
38
2
CRM
47
-2
PGR
69
5
NVDA
66
-2
MMC
67
2
SWK
56
3
HIG
71
4
SLB
37
5
GE
65
8
BLK
64
17
AZO
50
7
PG
58
3
NWS
69
-4
COST
74
2
WFC
58
3
WRK
52
2
VMC
62
2
CAG
31
-2
Financhill
Back

PIMCO Corporate & Income Opportunity Fds Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
58

PTY
PIMCO Corporate & Income Opportunity Fds

Last Price:
14.22
Seasonality Move:
0.98%
Sell
41

RARE
Ultragenyx Pharmaceutical

Last Price:
39.04
Seasonality Move:
3.65%
Buy
58
PIMCO Corporate & Income Opportunity Fds (PTY) is a Buy

Is PIMCO Corporate & Income Opportunity Fds a Buy, Sell or Hold?

  • The current PIMCO Corporate & Income Opportunity Fds [PTY] share price is $14.21. The Score for PTY is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • PTY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.80. The Score for RARE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PTY Stock Price Chart

What is PIMCO Corporate & Income Opportunity Fds's stock price today?

  • The PIMCO Corporate & Income Opportunity Fds share price today is $14.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTY is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

PTY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 40.28 Sell
Chaikin Money Flow: -288614 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.18 - 14.48) Sell
Bollinger Bands (100): (13.94 - 14.62) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 44 Sell
Chaikin Money Flow: 896649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.57 - 42.35) Sell
Bollinger Bands (100): (41.42 - 48.86) Sell

PTY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.44 Sell
20-day SMA: 14.38 Sell
50-day SMA: 14.25 Sell
200-day SMA: 13.82 Buy
8-day EMA: 14.37 Sell
20-day EMA: 14.37 Sell
50-day EMA: 14.32 Sell
200-day EMA: 13.99 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.65 Sell
20-day SMA: 40.82 Sell
50-day SMA: 42.69 Sell
200-day SMA: 42.45 Sell
8-day EMA: 41.15 Sell
20-day EMA: 41.29 Sell
50-day EMA: 42.49 Sell
200-day EMA: 43.61 Sell

PIMCO Corporate & Income Opportunity Fds Earnings Growth & PTY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.03 per share, an increase this year of $0.84 per share, and an increase next year of $1.07 per share.

PIMCO Corporate & Income Opportunity Fds Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):